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ABSTRACT 
The work is focused on the synthesis and the study of biocomposite materials for potential 
medical application. The theoretical part is a literature overview focused on different types of 
biomaterials especially on polyvinyl alcohol - hydroxyapatite (PVA/HA) composites. 
A set of polyvinyl alcohol (PVA) membranes with various weight percent - 0%, 10%, 20%, 
30%, 40% and 50% of hydroxyapatite (HA) were prepared. Hydroxyapatite was prepared by 
precipitation procedure using starting materials of diammonium hydrogen phosphate and 
calcium nitrate tetrahydrate in water alkaline environment and then mixed with solution of 
polyvinyl alcohol, which was prepared by dissolving it in water at 85°C. The different 
mixtures were casted in a mould and evaporated for 7 days at temperature 30 °C to obtain 
0,5 mm thin membranes. The ATR-FTIR spectroscopy was used to identify the different 
functional groups in composite membranes, XRD testing was carried out to identify 
crystallized hydroxyapatite. The tensile testing and TGA measurement were realised to find 
the effect of HA amount on the mechanical properties and thermal stability of the membranes. 
The in vitro bioactivity tests in Simulated Blood Fluid (SBF) were performed for 2 hours, 7 
and 28 days. SEM was used to characterise surface microstructure of biocomposite 
membranes before and after immersion in SBF. The surface of the tested membranes were 
analysed to investigate the formation of apatite, the characteristic of bioactivity. It was 
observed a formation of clusters within membranes with increasing amount of HA particles 
due to hydrogen bond and also the agglomeration and crystal growth of HA particles during 
drying of membranes. The bioactivity was found increasing with time immersion of 
biocomposite materials. 
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ABSTRAKT 
Dizertační práce se zabývá syntézou a studiem kompozitních materiálů pro potenciální 
lékařské využití. Teoretická část je zaměřena na biomateriály, zejména na kompozity složené 
z polyvinylalkoholu a hydroxyapatitu (PVA/HA). 
Byly připraveny kompozitní membrány složené z polyvinylalkoholu s různým hmotnostním 
zastoupením hydroxyapatitu - 0%, 10%, 20%, 30%, 40% a 50%. Hydroxyapatit (HA) byl 
připraven srážecí metodou z hydrogenfosforečnanu amonného a tetrahydrátu dusičnanu 
vápenatého ve vodném alkalickém prostředí. Vzniklá suspenze se smísila s roztokem 
polyvinylalkoholu, který byl připraven rozpuštěním ve vodě o teplotě 85° C. Jednotlivé směsi 
byly odlity do formy a sušeny po dobu 7 dní při teplotě 30 ° C, vzniklé 0,5 mm tenké 
membrány byly analyzovány ATR-FTIR spektroskopií k identifikaci funkčních skupin v 
kompozitu, dále byla provedena XRD analýza. Zkouška tahem a TGA měření byly 
realizovány k určení vlivu HA na mechanické vlastnosti, respektive změnu tepelné odolnosti 
kompozitů ve srovnání s čistým PVA. Byla provedena zkouška bioaktivity v simulovaném 
krevním roztoku (SBF) po dobu 2h, 7 a 28 dnů. SEM byla použita k charakterizaci povrchové 
mikrostruktury biokompozitních membrán před a po ponoření do SBF. Na povrchu 
testovaných membrán vznikla vrstva apatitu, která je charakteristická pro bioaktivní 
materiály. Bylo zjištěno, že s rostoucím množstvím HA v kompozitu docházelo ke vzniku 
aglomerátů, které vznikly mimo jiné jako důsledek růstu krystalů HA během sušení membrán. 
Bioaktivita rostla s delším působením SBF na vzorky. 
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1 THE AIM OF THE WORK 
 Draw up a literature overview focused on biomaterials especially on poly(vinyl 
alcohol)- hydroxyapatite (PVA/HA) composites; current state-of the-art. 
 Preparation of PVA/HA composites by precipitation method with variable amounts of 
HA in PVA matrix. 
 Characterisation of the composite properties. 
 Soaking samples in Simulated Body Fluid (SBF); detection of new structures created  
on sample surfaces after soaking; clarification of new structures formation. 
 To realise the aims of the PhD study the following methods will be used 
 Scanning Electron Microscopy (SEM)  
 Infrared spectroscopy by ATR (FTIR-ATR) 
 X-ray Diffraction (XRD) 
 Thermogravimetric analysis (TGA) 
 Tensile properties testing 
 Bioactivity in microincubator with SBF 
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2 INTRODUCTION 
People tried to replace bone tissue long time ago, the oldest proof is the neolithic golden slide 
found in Peru which was used as forehead bone replacement. About more then 1000 years ago 
bone implants were point of interest in Arabian countries, five hundred years ago the Aztecs 
were dealing with this question. 
Biological materials are used as replacement, increasingly non-biological materials as metals, 
metal alloys, ceramics, polymers and composites are applied. The required feature of 
materials used as implants is non-toxicity for living cells, non-inflammatory, non-
teratogenicity, non-mutagenicity and non-cancerous. In the present times ceramic surface 
bioactive materials are used as they successfully imitate the advantages of biological materials 
[1]. 
The development and use of biomaterials as implants in biomedicine is gaining in intensity 
since the end of the 20th century, as the life expectancy in developed countries exceeds the 
80. Those values are spectacular if compared with those corresponding to early 20
th
 century, 
around 40 years, while in Imperial Rome the life expectancy was only 22 years. Therefore, 19 
centuries passed before the expected lifespan doubled and then, in just one century, the 
20
th
 century, it doubled again. This spectacular rise is still ongoing, increasing the demand 
and the need for biomaterials. The ageing of the population involves certain problems that 
were not so generic some time ago, since fewer people reached those ages where the 
incidence of such diseases is more evident [2]. 
The definition of biomaterials is: "A biomaterial is a substance that has been engineered to 
take a form which, alone or as part of a complex system, is used to direct, by control of 
interactions with components of living systems, the course of any therapeutic or diagnostic 
procedure, in human or veterinary medicine"[3]. 
In any case, biomaterials are intended to interface with biological systems to evaluate, treat, 
augment or replace any tissue, organ or function of the body and are now used in a number of 
different applications throughout the body [4]. The major difference between biomaterials and 
other classes of materials is the ability of biomaterials to remain in a biological environment 
without damaging the surroundings and without being damaged themselves in the process. 
Thus, biomaterials are solely associated with the health care domain and they must have an 
interface with tissues or tissue components. One should stress that any artificial materials that 
are simply in contact with skin, such as hearing aids and wearable artificial limbs, are not 
included in the definition of biomaterials since the skin acts as a protective barrier between 
the body and the external world. The biomaterials discipline is founded in the knowledge of 
the synergistic interaction of material science, biological science, chemical science, medical 
science and mechanical science and requires input and comprehension from all these areas so 
that implanted biomaterials perform adequately in a living body and interrupt normal body 
functions as little as possible [5]. 
Engineering materials could be classified as metals, polymers ceramics and composites. In the 
same way, biomaterials are divided into biometals, biopolymers, bioceramics and 
biocomposites [5, 6]. 
When a synthetic material is placed within the human body, tissue reacts towards the implant 
in a variety of ways depending on the material type. The mechanism of tissue interaction (if 
any) depends on the tissue response to the implant surface. In general, there are three terms in 
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which a biomaterial may be described in or classified into representing the tissues responses. 
These are bioinert, bioresorbable and bioactive [7]. 
The term bioinert refers to any materials that once placed in the human body have minimal 
interaction with its surrounding tissue. Examples of these are stainless steel, titanium, 
alumina, partially stabilised zirconia,and ultra high molecular weight polyethylene.Generally 
a fibrous capsule might form around bioinert implants hence its biofunctionality relies on 
tissue integration through the implant (Figure 1a). Bioactive refers to a material, which upon 
being placed within the human body interacts with the surrounding bone and in some cases, 
even soft tissue. This occurs through a time - dependent kinetic modification of the surface, 
triggered by their implantation within the living bone. An ion exchange reaction between the 
bioactive implant and surrounding body fluids results in the formation of a biologically active 
carbonate apatite (CHAp) layer on the implant that is chemically and crystallographically 
equivalent to the mineralphase in bone. Prime examples of these materials are synthetic 
hydroxyapatite [8, 9]. (Ca10(PO4)6(OH)2), glassceramics A-W [9] and bioglass® [10], (Figure 
1b and c)). Bioresorbable refers to a material that upon placement within the human body 
starts to dissolve (resorbed) and slowly replaced by advancing tissue (such as bone). Common 
examples of bioresorbable materials are tricalcium phosphate (Ca3(PO4)2) and polylactic–
polyglycolic acid copolymers. Calcium oxide, calcium carbonate and gypsum are other 
common materials that have been utilised during the last three decades (Figure 1d) [12]. 
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Figure 1: Classification of bioceramics according to their bioactivity; (a) bioinert, alumina 
dental implant, (b)bioactive, hydroxyapatite (Ca10(PO4)2(OH)2)coating on a metallic dental 
implant, (c) surface active, bioglass, (d)bioresorbable tri-calcium phosphate implant 
(Ca3(PO4)2) [12] 
 
Depending on the function to perform, they can be manufactured from very different 
materials. It is known that the reactivity of solids begins on their surface. This general 
statement is of particular importance in the field of biomaterials, since they will be in contact 
with an aqueous medium and in presence of cells and proteins. 
Nowadays, it is possible to manufacture implants for any part of our body, except for the 
brain. Obviously, different types of materials are in use depending on the tissue to be 
replaced. If we focus on functional artificial biomaterials, the choice has to be made among 
metals, polymers and ceramics. Each group exhibits some a priori advantages and drawbacks. 
Ceramics, for instance, are the most biocompatible materials and can be obtained with 
bioinert, bioactive or bioresorbable properties, but their main drawbacks are their hardness 
and fragility. 
Metals exhibit problems of corrosion and toxicity, but their mechanical behaviour is optimum. 
Polymers offer many possibilities depending on their chemical composition and structure 
(biodegradability degree, hydrophilic/hydrophobic ratio, toughness/flexibility, etc.), but very 
few have shown good bioactive properties to ensure the implant osteo-integration. 
It is quite usual to use the three types of materials in the same implant. This is the case of a 
total hip joint prosthesis which presents a metal beam, partially coated with a bioactive 
ceramic, while the head is made of an inert ceramic and the socket is made of polymer [13]. 
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3 THEORETICAL PART 
The searching for ceramic bone substitutes started in the 1950s, and the first aim was to use 
inert materials which had no reaction with living tissues. Later on, in the 1980s, the trend 
changed towards exactly the opposite; the idea is to implant ceramics that react with the 
environment and produce newly formed bone. And then, in the current century, we are 
searching for new ceramics [5]. 
Table 1 shows different types of materials that are employed as bone substitutes. Basically, 
only metalloid materials, of the commercially available synthetic biomaterials, are 
mechanically good enough to reconstruct large cortical bone defects. Of donor materials, 
autograft is bone that is removed from the patient's own body, whereas allograft is bone that is 
removed from the same species (i.e. other humans). In addition, xenograft is also of biological 
origin; it is extracted from the inorganic phase of mammal bone but of some other species, 
typically e.g.that of neat. In fact, the use of autograft is drastically limited, because of the lack 
of availability and donor site morbidity limits. On the other hand, the risk of infection [14]. 
 
Table 1: The main material categories to reconstruct bone, and some of their typical 
disadvantages[14] 
ALLOGRAFT AUTOGRAFT 
Infection Risk 
Management of bone bank is difficult 
Expensive 
Lack of availability 
Damage to healthy bone tissues 
Secondary surgical procedure needed 
METALLIC MATERIALS POLYMER-BASED MATERIALS 
Metal-bone interface mechanical 
Loosening risk 
Stress shielding 
High elasticity moduli not optimal for bone 
Release of nanoparticles 
Residual toxic monomers, e.g. 
Risk of exothermic effects, hypotonia, or 
heart and lung complications 
Risk of wear debris 
BIOCERAMICS AND BIOACTIVE 
GLASSES 
OTHER, e.g. Xenografts 
Brittleness 
Stress shielding 
High modulus of elasticity 
Infection risk 
Low strength 
 
The biomaterials for the biomedical applications have evolved through three different 
generations, namely first generation (bioinert materials), second generation (bioactive and 
biodegradable materials) and third generation (materials designed to stimulate specific 
responses at the molecular level) [16].  
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3.1 Biomaterials of first generation 
When synthetic materials were first used in biomedical applications, the only requirement was 
to ‘achieve a suitable combination of physical properties to match those of the replaced tissue 
with a minimal toxic response of the host’ [15]. They were the first-generation biomaterials, 
according to Hench’s classification, because they were inert so as to reduce the immune 
response and the foreign body reaction to a minimum [16]. 
3.1.1 Metals 
The first metallic materials successfully used during the twentieth century in orthopaedic 
applications were stainless steel and cobalt-chrome-based alloys. Ti and Ti alloys were 
introduced by the 1940s. NiTi shape memory alloys were developed by the 1960s and they 
seemed to open a whole new range of applications, due to their special mechanical behaviour, 
but the properly unsolved allergenic effect of Ni has hampered their use. Ti and its alloys, 
originally used in aeronautics, became materials of great interest in the biomedical field, due 
to their excellent properties that include a moderate elastic modulus of approximately 
110 GPa, a good corrosion resistance and a low density [16]. 
3.1.2 Ceramics 
The first generation of ceramics as biomaterials, called inert ceramics, were focused on 
natural bone subtitution. Well known examples are zirconia, titanium and alumina. which are 
primarily used in fabrication of femoral heads to substitute the damaged bones. These 
ceramics are biocompatible, but the living body reacts against the implants because they are 
of foreign nature and the implant made of this artificial material never transforms into bone 
[17]. 
3.1.3 Polymers 
Some examples of polymer biomaterials of the first generation are silicone rubber, PE, acrylic 
resins, polyurethanes, polypropylene (PP) and polymethylmethacrylate (PMMA) [16]. 
PMMA is typically used as a filler material (bone cement) for joint replacement surgical 
procedures [18]. PE, and more specifically UHMWPE, is particularly attractive for 
applications such as the liner of acetabular cups in total hip arthroplasties, in the tibial insert 
and patellar component in total knee arthroplastics and as a spacer in intervertebral artificial 
disc replacement. Its unique properties of high abrasion resistance, low friction and high 
impact strength, excellent toughness and low density, ease of fabrication, biocompatibility 
and biostability make it an ideal candidate for application as an implant [16, 19, 20]. 
3.1.4 Composites 
Polymer matrix composites are being increasingly studied for different applications ranging 
from coatings, load-bearing implants or biosensors [21]. Examples of polymers proposed as 
matrices in biomedical composites include poly(methylmethacrylate) (PMMA), polysulfone 
(PSU), poly(etheretherketone) PEEK or Epoxy resins [22]. 
3.2 Biomaterials of second generation  
The mechanism of bonding of bioactive glasses (composed of Na2O–CaO–P2O5–SiO2) to 
living tissue, was established in 1971 by L. Hench [23]. In 1984 L.Hench and J. Wilson [24] 
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sucessfully developed a new biomaterial, which was defined as bioactive., i.e. material with a 
specific response on interaction with living tissue [25]. 
3.2.1 Ceramics 
Ceramics of the second generation, when react with the physiological fluids, the layer of 
biological-type apatite on their surface is formed. Among these ceramics it could be 
mentioned some calcium phosphates and several compositions of glasses and ceramic glasses, 
which are manufactured as powders, porous pieces, dense pieces, injectable mixtures and 
coatings for the medical applications. They have an excellent features in terms of 
biocompatibility and bioactivity, but their mechanical properties are very poor [26]. 
The thermal and chemical stability of ceramics and durability makes ceramics good materials 
for inert implants. Ceramics are one of the few materials that are durable and inert enough to 
withstand the corrosive effect of body fluids. Ceramics are used for applications such as heart 
valves, orthopaedic implants and dental applications [27]. 
Ceramics have many wanted properties such as hardness, chemical stability and corrosion-
resistivity, but they are brittle. Therefore combinations with polymers, metals and other 
ceramics have been developed to achieve properties such as strength and elasticity. Ceramic 
coated, biocompatible metals have the strength and flexibility of metals and the ability of 
ceramics to function with biological systems [26]. 
 
3.2.1.1 Calcium phosphates 
HA (Ca10(PO4)6(OH)2), β-tricalcium phosphate (β-TCP, Ca3(PO4)2), their derivatives and their 
combinations are the mostly used ceramics. Depending on their synthesis process, these 
materials show different physical and chemical properties. HA shows excellent bioactive 
properties, after implantation HA remains integrated into the regenerated bone tissue, whereas 
TCPs are completely reabsorbed. There is a range of suitable CaPs that can be used as CaP 
cements (CPCs). These materials are injectable, harden inside the damaged bone tissue and 
generate low heat transfer that avoids the premature death of surrounding cells [16, 28, 29, 
30]. 
3.2.1.2 Bioactive glasses 
Profesor L. Hench designed in 1968 an imaginative route to obtain new bone from a glass 
[31]. A piece of glass was soaked in an aqueous solution with the same ions present in the 
human plasma. The reaction product of the glass and the fluid was an apatite similar to 
biological ones. Although their bioactivity is excellent, the great problem of glasses is that 
their mechanical properties are very poor, which limits their application in the filling of small 
defects [11]. 
 
3.2.1.3 Glass ceramics 
In the 1960s the original work on Bioglass® by L. Hench was being undertaken. Kokubo et 
al. were developing a new glass-ceramic material in Japan and they first reported the 
production and behaviour of A-W glass-ceramic in 1982 [32]. 
Glasses also can be used as precursors in the production of glass ceramics [33]. The specific 
microstructure of glass ceramics reinforces the mechanical properties of the whole piece. 
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Therefore, it is possible to obtain bioactive glass ceramics with mechanical properties much 
closer now to those of the natural teeth [34]. 
Apatite-wollastonite (A-W) glass-ceramic became one of the most extensively studied glass 
ceramics for use as a bone substitute. Apatite-wollastonite glass-ceramic is an assembly of 
small apatite particles effectively reinforced by wollastonite. The bending strength, fracture 
toughness and Young’s modulus of A-W glass-ceramic are the highest among bioactive glass 
and glass-ceramics, enabling it to be used in some major compression load bearing 
applications, such as vertebral prostheses and iliac crest replacement. It combines high 
bioactivity with suitable mechanical properties [35]. 
3.2.2 Metals  
None of the metallic materials used in orthopaedics is bioactive per se. However, two 
methods can be considered to obtain bioactive metals. The first one consists of coating the 
surface of the implant with a bioactive ceramic (HA and BGs). The second one is to 
chemically modify the surface of the material so as to obtain the deposition of a bioactive 
ceramics in vivo or to induce proteins and cell adhesion and other tissue/material interactions. 
Some of the coating methods of the first approach include electrophoretic deposition, plasma 
spraying, radio frequency or ionic ray sputtering, laser ablation or hot isostatic pressure. None 
of these methods produce covalent links with the substrate, and the majority are not cost-
effective. However, HA coating by plasma spray deposition is at present the most common 
method used for clinical applications. In this process, HA in its plasma state (greater than 
1000°°C) is projected against a colder material metallic surface (100–150°°C). By cooling 
down rapidly, a mechanical interaction is created between the ceramic and the substrate [16]. 
3.2.3 Polymers  
This second generation is classified as group of resorable polymers. Biodegradable polymers 
of synthetic and natural origin such as polyglycolide (PGA), polylactide (PLA), 
polyvinylalcohol (PVA), hyaluronic acid and other hydrogels are greatly studied currently. 
Biodegradability is mainly originated by hydrolysis of the polymer chain backbone and to a 
lesser extent by enzymatic activity [16, 36, 37] 
 
3.3 Composites  
Composite materials reinforced with ceramic particles or fibres both biodegradable and inert 
can be considered to have been developed during the last 30 years. The well known composite 
of this generation is HAPEX, which consists of PE and HA particles as the filler, which is 
clinically used for middle ear and orbital floor implants [12]. 
Bioabsorbable composites for bone repair applications were developed following the first 
generation so-called bone-analogue concept proposed by [38] and [39]. It is necessary to point 
out that in the case of Bonfield’s composite, as well as some others, the concept is a bioactive 
non-biodegradablematerial: HAPEX consists of a PE matrix reinforced with HA particles. HA 
acts as the bioactive agent that promotes osteoblast attachment, while PE, the matrix,is a 
stable, non-biodegradable inert polymer. It is worth mentioning that HAPEX has been 
successfully commercialized for middle-ear implant applications [40]. PVA/HA composite 
has been extensively studied as implant [16]. 
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3.4 Biomaterials of third generation 
Whereas second-generation biomaterials were designed to be either resorbable or bioactive, 
the next generation of biomaterials is combining these two properties, with the aim of 
developing materials that, once implanted, will help the body heal itself. Two alternative 
routes of repair are now available with the use of these tailored biomaterials - Tissue 
engineering and in situ tissue regeneration [41]. 
3.4.1 Scaffolds for tissue engineering 
Tissue engineering attempts to develop artificial materials able to replace biological tissues in 
situations where the human body cannot perform replacement by itself. One attempt consists 
on designing biomimetic materials that combine synthetic materials with cellular recognizing 
positions. These hybrid materials can yield surfaces with better properties. There are some 
difficulties to choose the specific type of cell from the huge universe of them. It is also 
difficult to induce functionality and architectures in multiple cells when they react with the 
surface of a biomimetic material [26]. 
Progenitor cells are seeded onto modified resorbable scaffolds. The cells grow outside the 
body and become differentiated and mimic naturally occurring tissues. These tissue 
engineered constructs are then implanted into the patients to replace diseased or damaged 
tissues. With time the scaffolds are resorbed and replaced by host tissues that include a viable 
blood supply and nerves [41]. The design of scaffolds able to guide cell growth is an 
important challenge in tissue engineering. The aim is to fabricate pieces that support and 
structure the newly formed tissue and said pieces have to be made of the most suitable 
materials for these tasks. Biological cells must be cultured onto this support and subsequently 
give rise to the growth of new tissue. At present, the aim is to find biomaterials which induce 
the regeneration of hard tissues stimulating the response of the cells involved. The 
requirements for these ceramics are to act as a scaffold and also to be porous so that the cells 
can do their job. It is worth recalling the concept of porosity and its range of order. Those 
materials with mesoporosity between 2 and 50 nm are of interest for applications where drugs 
or biologically active molecules are loaded, and later released to help in the bone regeneration 
process. Macroporous materials, where the pore sizes are in the order of microns, are adequate 
as scaffolds for tissue engineering [42]. 
3.4.2 In situ tissue regeneration. 
This approach involves the use of biomaterials in the form of powders, solutions, or doped 
microparticles to stimulate local tissue repair. Bioactive materials release chemicals in the 
form of ionic dissolution products, or growth factors such as bone morphogenic protein 
(BMP), at controlled rates, by diffusion or network breakdown, that activate the cells in 
contact with the stimuli. The cells produce additional growth factors that in turn stimulate 
multiple generations of growing cells to self-assemble into the required tissues in situ along 
the biochemical and biomechanical gradients that are present [41]. The development of 
materials for any replacement application should be based on the understanding of the 
structure to be substituted. This is true in many fields, but particularly exigent in substitution 
medicine. The demands upon the material properties largely depend on the site of application 
and the function it has to restore. Ideally, a replacement material should mimic the living 
tissue from a mechanical, chemical, biological and functional point of view [22]. 
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3.5 Composites 
A composite material consists at least two chemically identified phases which are separated 
by interface(s). The properties of composites are strongly influenced by a number of factors 
e.g. filler shape, size and size distribution, properties and volume percentage of filler, matrix 
properties (e.g. molecular weight), dispersion of filler particles in the polymer matrix and the 
state of the filler/matrix interface. In the case of biocomposites, other factors such as 
biocompatibility of the filler or matrix, the degradation rate of matrix and non-toxicity [43] 
must be considered. Physical characteristics such as shape, size, and size distribution of filler 
particles are very important in determining the mechanical properties of a composite.  
Irregular shape of the filler is preferred to the spherical, as the molten polymer can easily 
penetrate onto the particle surface and forms a mechanical interlock with the particle, 
contrarily the smooth surface of spherical particles does not allow such a joining to form a 
locking mechanism. Consequently, the absence of chemical bonding between the polymer and 
the particle will influence the mechanical properties of the composite [44]. 
The composites can be divided into groups according to connecting interaction between the 
components of composite. Commonly one of these compounds is inorganic and the other one 
organic in nature. The first class are those that show weak interactions between the two 
phases (van der Waals, hydrogen bonding or weak electrostatic interactions). The second 
class of hybrid materials have strong chemical interations between the components (covalent, 
coordination, ionic) or without chemical interactions between the two components [45].  
 
Kickelbick designed four types of mutual arrangements of nano-sized particles to a polymer 
chain. 
(1) inorganic particles embedded in inorganic polymer, 
(2) incorporation of particles by bonding to the polymer backbone,  
(3) an interpenetrating network with chemical bonds,  
(4) an inorganic-organic hybrid polymer. 
 
 
Figure 2: Four types of mutual arrangements of nanoparticles to a polymer chain according 
to Kickelbick: (1) inorganic pa rticles embedded in an inorganicpolymer, (2) incorporation of 
particles by bonding to the polymerbackbone, (3) interpenetrating network with chemical 
bonds, (4)inorganic–organic hybrid polymer [45] 
3.5.1 Nanocomposites 
Nanocomposites are materials defined as composites being reinforced with particles having at 
least one dimension in a nano meter size range. Common example of nanocomposites is the 
structure of bones. A bone has a complex arrangement of materials and structures at different 
length-scales, which work in synergy to perform diverse mechanical, biological and chemical 
functions, such as: structural support, protection and storage of healing cells, and mineral ion 
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homeostasis. The structure of bone can be described as a hierarchical organisation. The 
different levels of this structure are: (1) the macrostructure: cancellous and cortical bone; (2) 
the microstructure (from 10 to 500 μm): Haversian systems, osteons, single trabeculae; (3) the 
sub-microstructure (1–10 μm): lamellae; (4) the nanostructure (from a few hundred 
nanometres to 1 μm): fibrillar collagen and embedded mineral; and (5) the sub nanostructure 
(below a few hundred nanometres): molecular structure of constituent elements, such as 
mineral, collagen, and non-collagenous organic proteins (Fig.3). The structure is made more 
complex by the 3D arrangement and orientations of the different components. 
 
 
 
 
Figure 3: Hierarchical structure of bones: a) cortical and cancellous bone; b) osteons with 
Haversian systems; c) lamellae; d) collagen fibre assemblies of collagen fibrils; e) bone 
mineral crystals, collagen molecules and non-collagenous proteins. From [46, 47] 
 
Nanoparticles were firstly introduced in the 90
th
 of last century, since then the most of the 
effort was focused on the preparation and understanding the behavior of nanocomposites. It 
has been reported that at the nanoscale (below about 100 nm), a material’s property can 
change dramatically. With only a reduction in size and no change in the substance itself, 
materials can exhibit new properties such as electrical conductivity, insulating behavior, 
elasticity, greater strength, different color, and greater reactivity-characteristics that the very 
same substances do not exhibit at the micro or macroscale [48]. 
First concepts to characterise nanocomposite behaviour were established for microcomposite 
and were just scaled three orders of magnitude lower to describe and understand the 
nanocomposite behavior. It was shown by Jancar et al. [49, 50, 51], this approach might not 
be correct. With decreasing particle size, the specific surface area increases. The large portion 
of polymer is in an intimate contact with the filler surface and takes a maximum advantage of 
interphase area. This has a strong influence of several composite properties like stiffness. 
Particles with high specific surface area tend to form aggregates easily (Fig. 4). 
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Figure 4: Increasing size and decreasing specific surface area of nanoparticles - From 
nanocomposites on the right to a micro composite on the left. Simplified example of 
hierarchically organized structures found in nanocomposites [52]. 
 
The aggregates formation is managed by the need for an optimal surface to volume ratio. 
Several methods exist to avoid the agglomeration. These procedures are focused on  
preventing the aggregation applying a surface treatment and with using an external field. 
However, nano spheres tend to form agglomerates easily unless a protective colloid is used to 
keep them separate. It was shown that spherical nanoparticles can assemble into stripes under 
a loading [52]. 
Akcora et al. [59] showed a broad effect of self-assembled nanoparticles under a broad range 
of conditions into a variety of superstructures. By varying the quality of solvent, annealing 
time, chain length and grafting density, a various super-organized structures were found. The 
effect of aggregates on the deformation behavior was always considered as negative. It was 
believed that the deformation behavior for well separated particles yields to the largest 
mechanical response, for example - stiffness. However, the question of reinforcement 
efficiency for well-dispersed or percolated particles is not fully answered, yet. There is no 
doubt that the incorporation of nano-spherical particles with large specific surface area leads 
to the amplification of several molecular processes resulting in an enhanced macroscopic 
properties.  
The effect of nanoparticles on the matrix properties and the relationship between nano-scale 
structural variables and the macro-scale properties of polymer nanocomposites remains in its 
infancy [51]. 
Aggregation and agglomeration phenomena are very important points. It can be simply 
calculated that for particles below approximately 10 µm thermally activated Brownian motion 
prevails gravitation forces. Particular characteristic of colloidal particles is very large surface 
area of the interface region.  
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Stability of colloidal dispersion can be viewed in sense of thermodynamics by free energy, G, 
at constant temperature and pressure as [53] 
 
dG = γdσ                          (1)  
where γ is surface tension and dσ is surface area change (dσ = 
N
i
idó ).  
Thus, the increase in the interface area causes increase of the free energy. Due to surface 
tension the interface is connected with possitive additional Gibbs free energy [54] and as 
inner surface area of particles increases the stability of suspension becomes 
thermodynamically inconvenient. In suspension where interparticle collisions take place, the 
interaction between two particles may be formalized according familiar Leonard-Jones 
potential U, and interparticle distance, r. 
 
U ≈ Urepulsion – Uattraction ≈ r
-12
 – r-6                    (2) 
 
Long-range attraction forces, which cause aggregation, can be disturbed by creating a shell 
around each particle that supports dispersion stability (from thermodynamics point of view 
the system become metastable). It is usually carried out by adsorption of molecules or ions on 
the particle surface [53, 55]. 
 
3.6 Hydroxyapatite 
Hydroxyapatite is described as one of the most bioactive ceramics widely used as powder or 
in particulate forms in various bone repairs and as coating for metallic prostheses to improve 
their biological properties. It has excellent biocompatibility, bioactivity and osteo-conduction 
properties. HA is thermodynamically the most stable calcium phosphate ceramic compound 
nearest to the pH, temperature and composition of the physiological fluid [56]. 
Contrarily HA is fragile and has low tensile strength, due to those it can not be use to replace 
bone in load bearing sites. 
HA is the main inorganic mineral constituent of bones, enamel, dentine and pathologically 
calcified tissues. Hydroxyapatites are naturally-occurring forms of calcium apatites with 
chemical formula of Ca5(PO4)3(OH), but it is usually written as Ca10(PO4)6(OH)2 because the 
crystal unit cell is made up of two molecules. The pure HA powder is white in colour [57]. 
Apatites belong to the family of calcium phosphates and are represented by the general 
formula Me10(XO4)6Y2. The Me atoms correspond for divalent cations (Ca, Ba, Pb) suitable 
for substitution by monovalent (Na, Rb, Cs) or trivalent (Al, Nd, La) cations, while the XO4 
group is a trivalent anion (PO 34  , VO
3
4 ) able to be substituted by tetravalent or divalent 
groups (SiO 44 , GeO
4
4  or SO
2
4 , CO
2
3 , HPO
2
4 ). The charge is balanced by monovalent 
anions Y such as F
-
 (fluorapatite), Cl
-
 (chlorapatite), OH
-
 (HA). The structure makes apatites 
chemically and thermally stable [58]. 
22 
 
 
 
 
Figure 5: Crystal structure of hydroxyapatite [59]. 
 
The bone consists of organic components (mostly collagen fibres) and inorganic 
mineralphase, known as biological hydroxyapatite which represents 65-70 wt% of natural 
bone [60]. Collagen fibres keep bones resilient, while mineral component is responsible for 
the bone stiffness (Fig. 6). The most compatible with bone mineral phase is non-
stoichiometric calcium phosphate of “apatiticstructure” It differs from stoichiometric 
hydroxyapatite of formula Ca10(PO4)6(OH)2 with molar ratio of Ca/P = 1.67 [61]. Bone 
contains carbonated HA crystals in the form of plates and needles with length about 40–60 
nm, width 20 nm and thickness 1.5–5 nm [58]. 
Biological apatites are non-stoichiometric, mostly Ca-deficient with respect to phosphate 
(Ca/P < 1.67) unless carbonate ion is incorporated, then Ca/P is higher than 1.67. The 
difference between stoichiometric hydroxyapatite and bone mineral is founded in the impurity 
content, which is associated mostly with ions substitution for calcium sites in the bone 
hydroxyapatite structure [61]. This ratio can be an important factor in cell adhesion, 
proliferation and in bone remodelling and formation. Calcium-deficient HA is of greater 
biological interest because the mineral portion of the hard tissue is primarily carbonate 
substituted calcium-deficient HA, with a Ca/P ratio of about 1.5, which is chemically and 
compositionally similar to tricalciumphosphate but structurally similar to stoichiometric 
hydroxyapatite [44]. 
The natural sources of HA are animal bones and corals or can be synthetized from appropriate 
substrates. HA materials made from animal bones inherit some properties such as chemical 
composition and structure [62, 63]. 
HA is a crystal of hexagonal structure with the space group P63/m. The lower 
crystallographic symmetry induces mechanical anisotropy along each axis. The a, b plane is 
bio-active, the c plane is bioinert. That’s why a specific crystal orientation is required HA 
should be used as a biomaterial [44]. 
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Figure 6: A schematic diagram illustrating the assembly of collagen fibers and bone minerals 
crystals [71]. 
 
3.6.1 HA mechanical properties 
Ideally, a bone substitute should be replaced by a mature bone without transient loss of 
mechanical support. Unfortunately for material scientists, a human body provides one of the 
most inhospitable environments for implanted materials. It is warm, wet and both chemically 
and biologically active. Furthermore, the body is capable of generating quite massive force 
concentrations and the variance in such characteristics among individuals might be enormous. 
All types of potential biomaterials and bioceramics must sustain attacks of a great variety of 
aggressive conditions. Regrettably, there is presently no material fulfilling all these 
requirements. On the other hand, any ceramics, when they fail, tend to do so in a dramatic 
manner. The brittle nature of calcium orthophosphate bioceramics is attributed to high 
strength ionic bonds. Thus, it is not possible for plastic deformation to happen prior to failure, 
as a slip cannot occur. Consequently, if a crack is initiated, its progress will not be hindered 
by the deformation of material ahead of the crack, as would be the case in a ductile material 
(e.g., a metal). The crack will continue to propagate, rapidly resulting in a catastrophic failure 
[64, 65].  
From the mechanical point of view, calcium orthophosphate bioceramics are brittle 
polycrystalline materials for which the mechanical properties are governed by crystallinity, 
grain size, grain boundaries, porosity and composition [66]. The mechanical properties 
decrease significantly with increasing content of an amorphous phase, microporosity and 
grain size, while a high crystallinity, a low porosity and small grain size tend to give a higher 
stiffness, a higher compressive and tensile strength and a greater fracture toughness. Thus, 
calcium orthophosphate bioceramics possess poor mechanical properties that do not allow use 
in load-bearing areas, such as artificial teeth or bones [65, 67, 68].  
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3.6.2 HAP preparation 
Techniques to prepare HA include mechano-chemical synthesis and combustion preparation. 
Often used methods of HA preparation are wet chemistry techniques such as direct 
precipitation from aqueous solutions, electrochemical deposition, sol-gel method, 
hydrothermal synthesis and emulsion or micro-emulsion routes are often used [69]. The solid 
state synthesis of HA from oxide or inorganic salt powders usually requires extensive 
mechanical mixing and long heat treatments at high temperatures. These processing 
conditions, however, do not allow facile control over micro-structure, grain sizeand grain size 
distribution in the resulting powders or shapes [70]. This reason makes the wet chemistry 
techniques for HAP more suitable [71]. 
3.7 Poly(vinyl alcohol) 
Polyvinyl alcohol was discovered in 1915 by F. Klatte. The stochiometric saponification of 
polyvinyl acetate with caustic soda to yield polyvinyl alcohol was first described in 1924 by 
W. O. Herrmann and W. Haehnel. The monomer „vinyl alcohol“ is theoretically the enol form 
of acetaldehyde but can not exist as a monomer in practice. [72]. 
Polyvinylalcohol is a water soluble and biodegradable synthetic polymer. For food use it is an 
odourless and tasteless, translucent, white or cream coloured granular powder. PVA is slightly 
soluble in ethanol, but insoluble in other organic solvent [73]. 
PVA is an excellent adhesive with superior bonding strength, film forming and emulsifying 
properties. The film of PVA exhibits outstanding resistance to oil, grease and solvents. In 
addition to its film forming property, it has excellent adhesion to both hydrophilic and 
hydrophobic materials. PVA has been extensively used in textile industry for warp sizing and 
resin finishing, in paper industry for surface sizing and pigment coating, in the production of 
PVAc emulsion as protective colloid, in the suspension polymerization of PVC as a 
dispersion agent; as binder for ceramics, magnet, foundry cores and pigments [74]. Polyvinyl 
alcohol is used in cosmetics as a binder, film former and viscosity-increasing agent. It is used 
at various concentrations up to 25% of the formulation in 1994 according to the FDA. PVA is 
also used by the plastic industry for various applications and in pharmaceutical products as a 
viscosity increasing agent as well as a lubricant in ophthalmic solutions. It is also used for 
several clinical applications and has been investigated as a potential carrier molecule for 
internal tumour investigations [75]. 
3.7.1 Manufacture of poly(vinyl alcohol) 
The material used in the manufacture of polyvinyl alcohol is vinyl acetate monomer, which 
unlike vinyl alcohol, is stable. The polyvinyl acetate produced then undergoes alcoholysis. As 
the technical properties of polyvinyl alcohol depend in the first place on the molar mass and 
residua acetyl group content, industrial manufacturing processes are designed to ensure exact 
adherence to these parameters [76].  
The most important properties which the most of applications depend on are degree of 
polymerization and degree of hydrolysis. The degree of polymerization is an expression of the 
size of polymer. The higher the degree of polymerization of polymer is, the bigger the size 
and the longer the length of polymer is. Similarly, the degree of hydrolysis is an expression of 
the ratio of hydrophilic alcohol group and hydrophobic acetate group [74]. 
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3.7.2 Properties based on degree of polymerization 
The higher degree of polymerization of polymer is, the higher viscosity of solution and 
adhesion strength of film are. 
The higher degree of polymerization of polymer is, the less water solubility and the higher 
solvent resistance are. 
The higher the degree of polymerization of polymer is, the higher tensile strength of PVA 
film is. 
The higher the degree of polymerization of polymer is, the less penetration and softness of 
film is. 
The higher the degree of polymerization of polymer is, the better protective ability is [74]. 
3.7.3 Dissolving properties based on degree of hydrolysis 
Fully hydrolyzed grade PVA can be easily dissolved in over 90°C water, but it only swells in 
room temperature water [74].  
Partially hydrolyzed grade PVA can be slowly dissolved in room temperature water. But in 
normal uses, raising temperature to 90°C is necessary for saving dissolving time. Super low 
hydrolyzed grade PVA can be dissolved in 25°C to 50°C water [76].  
 
3.7.3.1 Manufacture of polyvinylacetate 
Polymerisation takes place on the principle of radical chain polymerisation in an organic 
solvent, usually methanol. The necessary radicals are provided by initiators with peroxy- or 
azo groups as a result of decomposition in the reaction mixture. The methanol in this performs 
several functions. During polymerisation it acts as a chain transfer agent and, together with 
the type and quantity of initiator, enables the molar masses to be adjusted to various values. 
By evaporative cooling it also serves to remove the heat produced in polymerisation, and 
finally it is used for alcoholysis of the polyvinyl acetate. At present both continuous and 
discontinuous processes are still in use for vinyl acetate polymerisation. 
 
 
Figure 7: Preparation route of polyvinyl alcohol from polyvinyl acetate 
 
The polyvinyl acetate dissolved in methanol is converted to polyvinyl alcohol by hydrolysis 
(alcoholysis), the reaction is catalysed by podium hydroxide [72, 77]. 
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3.7.4 Polymer chain 
The polyvinyl alcohol has the following structural formula (Fig. 8) [78]. 
 
 
 
Figure 8: Polyvinyl (alcohol) structure formula 
 
There is a strongly marked tendency towards mutual orientation in polyvinyl alcohol chains 
because of their polarity, both in aqueous solution and in the solid state. I. Sakurada has 
designed a structural model for such behavior [79]. 
 
Figure 9: Sakurada's structural model of polyvinyl alcohol [79]. 
 
 
Depending on the origin, type and thermal history of a polyvinyl alcohol, it is possible to 
determine the glass transition temperature [Tg] and crystallite melting point [Tk] by 
differential scanning calorimetry. Tg ranges between 40 and 80 °C, and Tk between 180 and 
240°C [79]. 
3.7.5 Poly(vinyl alcohol) in medical application 
Polyvinyl alcohol hydrogel has been recognized as a substitute material for the artificial 
articular cartilage due to its hydrophilicity and microporous structure, high elasticity, 
mechanical properties of absorption and exudation of body fluid. These properties of PVA 
hydrogel are closer to human body cartilage tissue than those of other artificial materials. On 
the other hand, PVA hydrogel presents poor strength and bioactivities. The shortcomings are 
overcome by adding hydroxyapatite as the reinforced phase to PVA composite hydrogel. 
PVA/HA composite hydrogel has been extensively studied as a cartilage substitute material 
[5, 80, 81]. 
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3.7.6 In vivo toxicity status  
The critical evaluation of PVAs reported that PVA was of low oral toxicity, poorly absorbed 
by the gastro-intestinal tract, did not accumulate in the body after oral administration, was not 
mutagenic or clastogenic and had a reported NOAEL of 5000 mg/kg bw/day in a 90-day 
dietary study and in a two-generation reproduction study (which was the highest dose tested). 
The authors concluded that „the existing information on PVA supports its safe use as a 
coating agent for pharmaceutical and dietary supplement products“ [82]. 
3.8 Poly(vinyl alcohol) – Hydroxyapatite composite 
Biocomposite materials based on polymer matrix reinforced with (nano)hydroxyapatite (gel) 
have been developed as an alternative biomaterial to titanium alloy in the replacement of 
diseased or damaged cartilage [83 - 85]. 
The use of PVA became very promissing in the last years for its excellent biocompatibility 
and biotribological properties [86 - 89]. Also, the characteristic that make it a potential 
biomaterial to replace the natural articular cartilage is its high porous structure with high 
content of free water, which is similar to that found in this soft tissue.  
The clinical application of the pure polymer brings some problems. The first problem is the 
durability of PVA. Attempts to improve hydrogel properties for load-bearing biomedical 
applications have included the introduction of composite materials such as rubber or glass, the 
use of cross-linking agents, and the use of freeze thawing procedures to induce partial 
crystallinity. The other major problem in clinical application is the articular cartilage fixation 
method. Since PVA-H itself does not adhere to tissue, longterm fixation of PVA implant by 
sutures is difficult.  
Therefore, a complex type artificial articular cartilage consists of PVA and a tissue-inducing 
material. Hydroxyapatite ceramic has already been used in the clinic for filling of bone 
defects due to its good biocompatibility and bioactivity. It can form bone-bonding with living 
tissue through osteoconduction mechanism [88].  
 
3.8.1 Interaction between HA and PVA 
The results of Fenglan [88] showed that two binding modes between hydroxyapatite and PVA 
molecules existed in the composites (Fig. 10): (1), The Ca
2+
 cation in the hydroxyapatite and 
inter-PVA molecules or intra-PVA molecule forms bond bridge band, and this can improve 
the rigidity of the network in the composites. (2), The hydroxyl group of hydroxyapatite and 
the free hydroxyl group in PVA molecules linked by the forms of hydrogen bond, and this can 
improve the interfacial bonding strength between hydroxyapatite and PVA polymer. It can be 
concluded that PVA polymer can provide a lot of free hydroxyl group to act with hydroxyl 
group on the surface of hydroxyapatite while the PVA concentration increases. As a result, 
the compressive strength of PVA gel increased with the rise of concentration of PVA solution 
[90]. 
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a) The interaction between Ca
2+
 cation and intra-PVA molecule 
 
 
(b) The interaction between Ca
2+
 cation and inter-PVA molecules 
 
 
(c) The hydrogen bond between nano-hydroxyapatite and inter-PVA molecules 
 
 
(d) The hydrogen bond between nano-hydroxyapatite and intra-PVA molecules 
 
Figure 10: The schematic diagrams of the interaction between hydroxyapatite and PVA 
polymers [88]. 
3.8.2 Mechanical properties of HA/PVA 
The unique mechanical behavior of nano-HA/PVA composites depends significantly on its 
special structure, which is composed of four parts such as amorphous region formed by PVA 
molecule, microcrystalline region by hydrogen bonding of intra- and inter-PVA molecular 
chains, nano-HA particles reinforcing phase and lots of free water among three-dimensional 
network structure of PVA gel. The elastic properties of the composites are attributed to the 
microcrystalline region of the composites and nano-HA particles. Both free water and 
amorphous region in the composites are beneficial to the viscous characteristics of the 
composites [90, 91]. 
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Generally, tissues are grouped into soft and hard tissues. Bone and tooth are examples of hard 
tissue whereas skin, blood vessels and cartilage are examples of soft tissue.Accordingly, hard 
tissues are intended to support loads, being stiffer (higher elastic modulus) and stronger 
(higher tensile strength) than soft tissues.The need for mechanical compatibility with hard 
tissue makes metals and ceramics to be many times considered more suitable than polymers 
for those type of applications. However, this is not true in many cases, basically because 
metals are much stiffer than human hard tissues and ceramics are not only more brittle but 
also stiffer than natural mineralised tissues. On the other hand unreinforced polymers are 
typically more ductile but not stiff enough to be used to replace hard tissues in load-bearing 
applications. Nevertheless, polymer based composites can be designed to meet stiffness and 
strength requirements for hard tissue substitution [22]. 
Matching the mechanical properties of implant with the ones of host tissue is the key 
mechanical compatibility factor in the biomaterial selection as bone replacements. 
Mismatching of stiffness will lead to a major load bearing on the implant device, and the 
surrounding bone tissue will experience less stress even after the fracture has been repaired. 
This phenomenon is called stress shielding or stress protection, which affects the bone 
remodeling and healing process. The underloaded bone adapts to the low stress environment 
and becomes less dense and consequently weak. Thus, failure of the implantation system is 
often found to be at the weak interface of the implant and the newly grown high porosity bone 
tissue [18, 89, 92]. Mechanical properties of some materials depicted in Fig. 11 and Table 2. 
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Figure 11: Tensile strength vs.modulus of materials with relevance for composite design 
when considering biomedical applications [93] 
 
Table 2: List of mechanical properties of some materials [94] 
Material Flexular 
strength[MPa] 
Elastic modulus 
[GPa] 
Hardness [GPa] 
Cortical bone 50 - 150 7 – 30 2 - 12 
Human tooth enamel 8 - 35 9 – 90 0.52 – 1.3 
Human tooth dentin 31 - 104 11 – 20 2.8 – 3.1 
Sintered HA 115 - 120 80 - 110 1.0 
3.8.3 PVA/HA composite application 
Poly vinyl alcohol - hydrogel (PVA-H) is widely used in biomedical fields, such as soft tissue 
replacement, drug delivery, and hemodialysis membranes for its excellent biocompatibility 
[95, 96]. The mechanical properties of PVA-H/HA composites have also been studied for use 
as an artificial blood vessel the most important properties of biomaterials used for artificial 
joints [97]. 
Porous composites may be used as drug delivery system because of ability to take in the drug 
molecules [98, 99]. An artificial cornea consisted of a porous nano-HA/PVA hydrogel skirt 
and a transparent center of PVA hydrogel has been prepared as well. The results displayed a 
good biocompatibility and interlocking between artificial cornea and host tissues [100, 101]. 
3.9 Bioactivity testing 
The materials developed for implants are tested by in vivo methods (in live animal organism) 
and by in vitro ones (in media simulating the body fluid). The tests are focused on their 
physical, chemical and mechanical properties and thus provide the basic information allowing 
the suitability of a material for implanting into the human organism to be assessed [102]. 
31 
 
Biomaterials used in implantological applications have to demonstrate besides the appropriate 
mechanical properties their bioactivity, hence the ability to promote bone tissue growth. Their 
bioactivity is attributed to the formation on their surfaces of a hydroxycarbonated apatite 
(HCA) layer similar to a large extent to the mineral part of bone. The rate of tissue bonding 
appears to depend on the rate of HCA formation, which follows a sequence of reactions 
between the implanted material and the surrounding tissues and physiological fluids [103].  
Kokubo proposed a mechanism of the HCA layer nuclation and growth. It consists in the 
interchange between Ca
2+
 ions of the glass and the H3O
+
 of the solution. This gives rise to the 
formation of Si-OH functional groups on the glass surface inducing thus apatite nucleation. 
The nuclei thus formed grow at the expense of the ions in the solution saturated with respect 
to the apatite [104]. In vitro tests are intended for use in screening bone bioactive materials 
before animal testing. The number of animals used and the duration of experiments can be 
significantly reduced by using these methods, which can assist in the efficient development of 
new types of bioactive materials [105]. Unfortunately, the in vitro test proposed by Kokubo is 
realised in static condition that is far from the biological realities in human body. The 
concentration of ions in SBF decreases with time and thus apatite formation can be stopped. 
These facts are illustrated by the results of investigations realized by [102] on the influence of 
SBF composition upon the formation of carbonated hydroxyapatite on the glass surface. The 
ion concentrations and pH of aqueous solution varied with testing period. It results from this 
study that the kinetics and mechanism of hydroxyapatite formation are influenced, not only by 
immersion time, but also by the variation of ion concentrations and pH of SBF in static 
regime [103, 105]. 
3.9.1 Simulated body fluids  
Simulated body fluids (SBF) are solutions that the chemical composition is similar to that of 
the human fluid (Table 3). These  solutions are used for in vitro tests of artificially prepared 
medical implants and the results serve to determine their properties such as biocompatibility, 
biodegradability, bio-availability, may use time, etc. The used SBF solutions are Ringer's 
solution, Hank's solution and variously modified solutions abbreviated as SBF. The SBF 
solutions began to be used in assessing the effects of bioactive glass on human organism. SBF 
solution was prepared for the first in 1995. This original SBF solution contained a high 
concentration of Cl
-
 ions and low concentration of HCO 3  ions compared to the plasma, 
consequently, it was necessary to adjust the solution [105]. 
Isotonic Ringer's solution (RS) can be used to simulate plasma, hemolymph environment or 
other extracellular fluid, which differ in the ion concentration, pH and osmotic pressure. The 
composition of the RS vary according to the type of animal (fish, birds) or tissues (muscle, 
bone) [106]. 
Hank's solution (HBSS) is a balanced saline and physiological solution (Table 3). There is a 
reduced level of calcium and regulated phosphate concentration. In some cases artificially 
there is magnesium in the form of sulphate (MgSO4) added. The solution may also be 
enriched with D-glucose. Balanced salt solutions(e.g. HBSS) were designed mainly for short-
term preservation of viable cells. It can also be used to wash the tissues and cells [107]. 
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Table 3: The ion concentrations (mol/l) of SBF in comparison with ions in blood plasma 
(BP), Ringer's solution (RS) and Hank's solution (HBSS). 
Solution Na
+
 K
+
 Mg
2+
 Ca
2+
 Cl
-
 HCO3
-
 HPO4
2-
 SO4
2-
 
BP 142.0 5.0 1.5 2.5 103.0 27.0 1.0 0.5 
SBF 142.0 5.0 1.5 2.5 148.8 4.2 1.0 0.5 
RS 39.1 1.4 0 0.4 40.7 0.6 0 0 
HBSS 141.7 5.7 0.8 1.7 147.6 4.2 0.7 0.8 
 
3.9.2 Mechanism of apatite layer formation in SBF 
The process of formation of apatite depends on the negativity of the surface, i.e. PO 34  and 
OH
- 
constitutes the negative group while Ca
2+
 constitutes the positive group of HAp (Fig. 
12(a)). The more the PO 34  and OH
- 
are exposed on the surface, the greater the negativity of 
the surface. These negative ions attract the positive Ca
2+
 ions from the SBF, thereby forming a 
layer of positive charge i.e. calcium-rich amorphous calcium phosphate (ACP) (Fig. 12(b)). 
Now the layer becomes positive with respekt to the surrounding SBF, which is enough to 
attract negative PO 34  and OH
- 
from the SBF and thereby forming calcium - poor ACP (Fig. 
12(c)). This gradually crystallizes to bone-like apatite (Fig. 12(d)) [108]. 
 
 
 
Figure 12: Schematic diagram of the process of formation of apatite on HAp surface. (a) HAp 
surface exposed to SBF under normal conditions, (b) kalcium ions settle on HAp surface from 
the SBF to form Ca-rich ACP, (c) calcium-rich HAp surface attracts phosphate groups from 
SBF to form Ca-poor ACP and (d) ageing produces apatite on the HAp surface [108] 
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3.9.3 HA bioceramics in vivo behaviour 
Shortly after implantation, a healing process is initiated by compositional changes of the 
surrounding bio-fluids and adsorption of biomolecules. Following this, various types of cells 
reach the bioceramic surface and the adsorbed layer dictates the ways the cells respond. 
Further, a biodegradation of the implanted bioceramics begins. This process can occur by 
either physicochemical dissolution with a possibility of phase transformation or cellular 
activity (so called, bioresorption), as well as by a combination of both processes. Dissolution 
is a physical chemistry process, which is controlled by some factors, such as solubility of the 
implant matrix, surface area to volume ratio, local acidity, fluid convection and temperature. 
For HA, the dissolution process in acids has been described by a sequence of four successive 
chemical equations: 
 
Ca10(PO4)6(OH)2 + 2H
+
 → Ca10(PO4)6 (H2O)2
2+
             (3) 
Ca10(PO4)6 (H2O)2
2+
 → 3Ca3(PO4)2 + Ca
2+
 + 2 H2O            (4) 
Ca3(PO4)2 + 2H
+
 → Ca2+ + 2CaHPO4                 (5) 
CaHPO4 + H
+
 → Ca2++ H2PO4
-
                   (6) 
 
With few exceptions, dissolution rates of calcium orthophosphates are inversely proportional 
to the Ca/P ratio, phase purity and crystalline size, as well as being directly related to the 
porosity and surface area. Bioresorption is a biological process mediated by cells (mainly 
osteoclasts and to a lesser extent, macrophages). It depends on the response of cells to their 
environment. Osteoclasts attach firmly to the implant and dissolve calcium orthophosphates 
by secreting an enzyme carbonic anhydrase or any other acid, leading to a local pH drop to 
~4–5 [5, 109].  
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4 EXPERIMENTAL PART 
4.1 Samples preparation 
4.1.1 Chemicals used 
Polyvinyl alcohol Mowiol 10-98 with Mw 61 000 from Clariant 
Diammonium hydrogen phosphate (NH4)2HPO4 from Sigma-Aldrich 
Calcium nitrate tetrahydrate Ca(NO3)2.4H2O from Sigma-Aldrich  
Ammonium hydroxide NH4OH from Sigma-Aldrich  
Distilled water for all the procedures was used. 
SBF – Simulated Body Fluid 
4.1.2 Preparation of hydroxyapatite 
In this work hydroxyapatite was prepared by the reaction using diammonium hydrogen 
phosphate and calcium nitrate tetrahydrate in distilled water in presence of additional NH4OH, 
which acts to conduct reaction to form nanoparticles (Equation 7). The suspension obtained 
can not easily sediment and the white yoghurt form is like gel. The pH was kept at high value 
around 13 - 14, this was controlled by ammonium hydroxide. Formed HA solution was rinsed 
to separate OH- ions until the pH of suspension was neutral. That was checked by simple pH 
paper indicator. 
The weighed portion of the precursors was calculated to maintain required molar ratio Ca:P at 
1, 67. It is necessary for biological response and producing a pure HA without minor fraction. 
Slight imbalances in the ratio of Ca/P can lead to the appearance of extraneous phases. If the 
Ca/P ratio is lower than 1.67, then alpha or beta tricalcium phosphate may be present after 
processing. If the Ca/P is higher than 1.67, calcium oxide (CaO) may be present with the HA 
phase [110]. 
 
Via this precipitation reaction hydroxyapatite with spherical particles were synthetised:  
 
                           
6(NH4)2HPO4 + 10 Ca(NO3)2 + 8NH4OH → Ca10(PO4)6(OH)2 + 20NH4NO3 + 6H2O (7) 
 
The sol-gel routine was the other way, which was HA prepared. The used solvent was 
ethanol. Diammonium hydrogen phosphate and calcium nitrate tetrahydrate were dissolved in 
ethanol, then mixed together. The temperature was kept at 80 °C and the pH was maintained 
at about 9 - 10 with ammonium hydroxide. The mixture was stirred for several hours until the 
high viscosity gel was obtained. This gel was dried and the newly formed HA was mixed with 
PVA solution. The mixture was found to be difficult to homogenise with PVA solution and 
the membranes created with this HA were not used for further testing, because the HA phase 
was separated during drying and it was not possible to disperse in the membrane body. 
4.1.3 Preparation of poly(vinyl alcohol)  
Clariant poly(vinyl alcohol) was dissolved in distilled water during constant stirring at the 
temperature 85 °C for 4 hours until all the solid polymer was dissolved. The amount of 
polymer used was 21 g dissolved in 400 ml of distilled water. 
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Table 4: Characterisation of used PVA Mowiol 10-98 [76] 
 Viscosity 
(4% solution at 
20°C) mPa s 
Degree of hydrolysis 
mol % 
Residual acetyl 
wt. % 
Mowiol 10-98 10 ± 1.0 98.4 ± 0.4 1.5 ± 0.4 
4.1.4 Composite membranes preparation 
Set of polyvinyl alcohol and hydroxyapatite composite membranes were made with various 
HA weight percent - 0%, 10%, 20%, 30%, 40% and 50%. Polyvinyl alcohol solution with 
temperature around 85 °C was stirred while adding calculated and weighed quantity of 
hydroxyapatite gel. This blend was mixed for 15 minutes to homogenise. Then 40 ml of the 
mixture was dosed into a mould with pipette. The mould has dimension 8 x 8 cm. This way 
prepared mixtures were dried at 30 °C for 7 days. After drying process, membranes of 
thickness near to 0,5 mm were removed and were ready for further testing. 
 
Table 5: Designation of prepared composites 
Composite components [in wt%] Designation 
0 HA + 100 PVA 0HA 
10 HA + 90 PVA 10HA 
20 HA + 80 PVA 20HA 
30 HA + 70 PVA 30HA 
40 HA + 60PVA 40HA 
50 HA + 50 PVA 50HA 
100HA + 0 PVA 100HA 
 
4.1.5 Simulated body fluid preparation 
In in vitro studies, the pH of the SBF solution is often buffered to 7.25-7.4 at 37ºC using 
tris(hydroxymethyl) aminomethane and hydrochloric acid. SBF is a highly saturated solution, 
thus precipitation of calcium phosphate can easily take place during preparation, storage and 
use. Simulated body fluid is an acellular, aqueous medium that has inorganic ion 
concentrations similar to those of human extracellular fluid, in order to reproduce formation 
of apatite on bioactive materials in vitro. This fluid can be used for not only evaluation of 
bioactivity of artificial materials in vitro, but also coating of apatite on various materials under 
biomimetic conditions. The composition of prepared SBF was in mmol/l: 142.0 Na
+
, 5.0 K
+
, 
1.5 Mg
2+
, 2.5 Ca
2+
, 148.8 Cl
-
, 0.5 SO4
2-
, 1.0 HPO4
2-
 and 4.2 HCO3
-
). 
 
SBF was prepared by dissolving the components 8.035 g NaCl, 0.355 g NaHCO3, 0.225 g 
KCl, 0.231 g K2HPO4·3H2O, 0.311 g MgCl2·6H2O, 0.292 g CaCl2·6H2O, 0.072 g Na2SO4 per 
litre of ultrapure water in a beaker according to the protocol given by Kokubo [111]. 
The medium was buffered to pH 7.3-7.4 at 36.5 ±0.5 ºC with 6.118 g tris(hydroxymethyl) 
aminomethane ((HOCH2)3CNH2) and hydrochloric acid (HCl) to achieve the buffering 
capacity of blood. In preparation of SBF, each chemical was added after assuring the previous 
chemical dissolved fully to avoid any unexpected chemical reactions among them. Each small 
undesired variance in the preparation steps and the storage temperatures, may drastically 
affect the phase purity and high temperature stability of the produced HA on the surface, as 
well as the kinetics of the precipitation processes. 
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Sodium azide (NaN3) was added to inhibit bacterial growth. The microbiological assay of 
SBF medium indicated the necessity of NaN3 addition to inhibit the growth of bacteria. Gil 
[135] stated that the use of SBF without of NaN3 addition led to enormous increase of cells 
(10
4
-10
5
 /ml) in the form of coliform bacterium, bacterium bacillus and Pseudomonas after 
cultivation in culture media at 37 °C. These anaerobic bacteria consume phosphorus and thus 
reduce its concentration in the medium. Furthermore, it was observed that these bacteria may 
have a negative impact on human health. 
4.2 Testing methods 
4.2.1 FTIR-ATR 
Attenuated total internal reflectance (ATR) spectroscopy is a versatile and powerful technique 
for infrared sampling. Minimal or no sample preparation is usually required for rapid analysis. 
ATR is ideal for those materials which are strong absorbers.  
The phenomenon of internal reflection was first reported in infrared spectroscopy in 1959. It 
was observed that if certain conditions were met, infrared radiation entering a prism made of a 
high refractive index infrared transmitting material (ATR crystal) will be totally internally 
reflected. This internal reflectance creates an evanescent wave which extense beyond the 
surface of the crystal into the sample held in contact with the crystal. In regions of the infrared 
spectrum where the sample absorbs energy, the evanescent wave will be attenuated. 
The condition which must exist to obtain total internal reflectance is that the angle of the 
incident radiation θ, must exceed the critical angle, θc. The critical angle is a function of the 
refractive indices of the sample and ATR crystal and is defined as: 
 
1
2
sin 1-
n
n
c 
                         (8)  
 
where n1 is the refractive index of the ATR crystal and n2 is the refractive index of the 
sample. High refractive index materials are chosen for the ATR crystal to minimize the 
critical angle. 
A property of the evanescent wave which makes ATR a powerful technique is that the 
intensity of the wave decays exponentially with distance from the surfaře of the ATR crystal. 
The distance, which is on the  order of microns, makes ATR generally insensitive to sample 
thickness, allowing for the analysis of thick or strongly absorbing samples. 
The factors which effect the results obtained in an ATR experiment are the: wavelength of 
infrared radiation, refractive index of the ATR crystal, angle of incidence, efficiency of 
sample contact and area of sample contact with ATR crystal material [112]. 
4.2.2 Morphological characterization with scanning electron microscopy 
The surface morphology was examined through scanning electron microscope (JEOL JSM-
7600F). 
4.2.3 XRD diffraction analysis 
X-ray diffraction (XRD) is a basic method for determining the structure of solids. Each 
crystalline substance has a characteristic diffraction pattern by which we are able to identify 
it. This method is based on the interaction of X-rays with the electrons of atoms consisting of 
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a flexible variance. With regular periodic arrangement of atoms in a crystalline phase occurs 
after dispersion and subsequent interference of X-rays to the formation of diffraction peaks, 
the position, intensity and shape depend on the kind of atoms and their arrangement in 3D 
space. This process is governed by Bragg's law: 
 
2d sinn                         (9) 
 
where d is spacing between the planes in the atomic lattice, θ is the angle between the incident 
ray and the scattering planes, n is an integer characteristic and λ is the wavelength of incident 
wave. The diffraction pattern obtained allows to study of crystalline sample composition and 
microstructure [113]. 
 
Figure 13: Two cases of the impact of X-ray beam at the crystal lattice: left Bragg condition 
is fulfilled - the emergence of diffraction maxima, the right is not fulfilled - destructive 
interference [113]. 
 
For the XRD analysis was testing device Empyrean made by Panalytical used, measurement 
conditions were set as follows: 
 
Scan Axis        Gonio 
Start Position [°2Th.]     5.0066 
End Position [°2Th.]     89.9876 
Step Size [°2Th.]      0.0130 
Scan Step Time [s]     55.08 
Anode Materiál       Cu 
K-Alpha1 [Å]       1.54060 
K-Alpha2 [Å]       1.54443 
Generator Settings      30 mA, 40 kV 
4.2.4 Tensile properties 
In this study were tested 0HA, 10HA, 20HA, 30HA, 40HA and 50HA membranes. 
Samples were cut out into shape of dog-bone according to ISO system standard ISO 527 
(Fig. 14) The edges of the speciments were smooth, there was not requirement of any further 
treatment. Each sample used was previously inspected and those containing any defect such 
as air bubbles, holes. Width was constantly 4mm and thickness were gauged on 3 different 
points and averaged. The speciments were fixed into the grips of the testing machine. The 
38 
 
distance between sample holders was 40 mm. Each specimen was tested for 5 times and 
finally characteristic curves were chosen. 
For the investigation it was used universal materials testing machine ZWICK Z010/TH2A 
made by Zwick-Roell company (Germany). The tensile testing machine pulls the sample from 
both ends and measures the force required to pull the specimen apart and how is the strain 
before breaking. The speed of the measurements was constantly set at 20 mm/min. 
 
Figure 14: Dog-bone sample for tensile properties testing according to standard (ISO 527-2) 
 
Figure 15: Typical stress strain curves [114] 
Curve a –Brittle materials; Curves b and c – Tough materials with yield point; Curve d - 
Tough materials without yield point 
4.2.5 Thermogravimetric Analysis (TGA) 
The thermogravimetry analysis (TGA) is a technique which has been defined by ICTAC (the 
International Confederation for Thermal Analysis and Calorimetry) as a technique in which 
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the mass change of a substance is measured as a function of temperature whilst the substance 
is subjected to a controlled temperature programme [115]. 
Thermogravimetric analysis is the most widely used thermal method. It is based on the 
measurement of mass loss of material as a function of temperature. In thermogravimetry a 
continuous graph of mass change against temperature is obtained when a substance is heated 
at a uniform rate or kept at constant temperature. A plot of mass change versus temperature 
(T) is referred to as the thermogravimetric curve (TG curve). For the TG curve, we generally 
plot mass (m) decreasing downwards on the y axis (ordinate), and temperature (T) increasing 
to the right on the x axis [116]. 
Thermogravimetry is also widely used both in studies of degradation mechanism and for 
methods for service lifetime prediction measurements [117]. Thermogravimetry could be used 
for obtaining information of desorption, decomposition and oxidation processes. 
Thermogravimetry provides the accelerated aging experiments; information on chemical 
groups or morphological characteristics susceptible to attack, attacking agents and factors 
accelerating the deterioration [114, 117, 119]. 
Thermogravimetry analysis was carried out on composite samples and single components 
(PVA, HA) non-isothermally using a 20°C min -1 heating rate up to 900°C.  
The TGA Q500 TA Instruments research-grade thermogravimetric analyzer was used. The 
measurement went under N2 condition and results were analysed with Universal V4.7A TA 
Instruments analyzer. 
The main goal of this measurement was to assess the effect of content of hydroxyapatite in 
PVA matrix on thermal stability. A derivative weight loss curve was used to determine the 
temperature at which weight loss was most apparent. 
4.2.6 Bioactivity testing 
The bioactivity of the membranes with various content of HA in PVA matrix were tested with 
in vitro SBF method. The SBF was prepared in laboratory. Cleaned samples of size 1x1 cm 
were immersed and stored in the incubation apparatus (Binder BD 115) for 2 hours, 7 and 28 
days at the temperature of 37.0 °C. The microstructure of membranes surface were tested 
before and after soaking in SBF by SEM. The samples were weighed before and after 
immersion to determine the extent of biodegradation or bioactivity. 
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5 RESULTS AND DISCUSSION 
5.1 XRD analysis 
Hydroxyapatite prepared by precipitation method was further analysed by XRD analysis. The 
analysis depicted in Fig.16 shows that synthesized sample was a pure HA and it crystallized 
in the hexagonal crystal system p63/m. No other impurities were observed in the pattern.  
 
Figure 16: XRD analysis of synthesized hydroxyapatite 
 
X ray diffraction pattern of pure PVA membrane is displayed in Fig.17. The observed 
maxima intensity diffraction peaks were at 11; 19,5; 23 and 40,5 ° 2theta and belonged to 
PVA XRD pattern. The calcite has been identified as it was used to fix the sample to the 
measurement target.  
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Figure 17: XRD pattern of poly(vinyl alcohol) used in membrane preparation 
5.2 FTIR-ATR 
The functional groups in PVA, HA and composite samples were identified and the nature of 
bonding between the particles and the polymer matrix were analyzed by FTIR-ATR 
spectroscopy analysis. The used apparatus was Nicolet i50 FTIR spectrometer with single 
bounce diamond crystal ATR accessory within the scanning range 4 000–400 cm_1. Spectra 
show several bands characteristic of stretching and bending vibrations of different functional 
groups like O-H, C-H, C=C and C-O groups. 
 
The FTIR spectra of different biocomposite membranes and the pure HA powder are depicted 
in Fig.18. The spectra are aligned from pure HA(100HA) powder, pure PVA (0HA) to 50HA 
composite. 
The spectrum of the pure HA powder: Bands at 630 and 3570 cm
-1 
indicate structural O-H 
groups in the HAp crystals. Bands located at about 1000 - 1100 and 560 - 570 cm
-1 
 are 
attributed to the ν3 and ν4 P-O vibration modes of regular tetrahedral PO43- groups. 
The observed bands at 604 cm-
1
 correspond to O-P-O bending and ν1 symmetric P stretching 
modes. The ν1 symmetric stretching mode of phosphate group is observed at 957 cm-1. Band 
at 1641 cm
-1 
 indicates the presence of H2O in HAp crystals [119]. 
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Figure 18: Spectra of HA powder(100HA), pure PVA(0HA) and PVA/HA composites with 
various amount of hydroxyapatite (10HA, 20HA, 30HA, 40HA, 50HA) 
 
The PVA spectrum indicates a wide and intense band due to the presence of hydroxyl groups 
(O-H) at 3441 cm
-1
. The bands corresponding to the (-CH2-) asymmetric and the symmetric 
stretching at around 2900 cm
-1
. The band at 1400 cm
-1
 can be attributed to O–H and C-H 
bending. The absorption peaks at 1110 cm
-1
 are related to C–O stretching. 
The band at 900 cm
-1
 results from an angular deformation outside the plan of O-H bond. The 
absorption bands at 1625 cm
-1
 are due to symmetric stretching of carboxylate anion (-COO-) 
[120].  
The PVA spectrum and composites spectrum show an increasing intensity of absorbance 
varying with the amount of HA in the samples in the adsorption range from 3000 cm
-1 
to 3500 
cm
-1
. Broad and strong band at 3360 cm
-1 
which characterizes O-H stretching frequency is 
well detected due the increasing presence of HA in composite materials.  
The intensity of spectrum at around 1330 cm
-1
 increases with increasing content of HA in 
samples and is assigned to the phosphate group PO4
3-
.  
There were detected changes in spektra after composite formation, the variation and shift in 
the band around 3300 – 3400 cm-1. The band observed between 2942-2944 cm-1 corresponds 
to C-H stretching band of PVA. A new peak of C-H stretching band is observed at 2944 cm
-1
, 
when the PVA is added. These changes mark the chemical bond interactions between HA and 
PVA in the composite. 
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5.3 Morphological characterisation with SEM 
The set of samples was arranged from 0HA,10HA, 20HA, 30HA, 40HA and 50HA to 
compare the transparency of the samples (Fig. 19). The expectancy was the transparency 
decreases with increasing amount of the filler in PVA matrix, which was proved to be true. 
The samples with increasing HA in PVA changes their colour into white. 
 
 
Figure 19: Membranes with various HA content in PVA matrix, from left to right 0HA, 10HA, 
20HA, 30HA, 40HA and 50HA 
 
The microstructure of PVA/HA composites with different weight percentages of HA in 
polyvinyl alcohol matrix, pure HA and pure PVA was analysed using scanning electron 
microscope (SEM). The SEM pictures are displayed in Fig. 20 - 26. The PVA matrix is 
continuous without bubbles. Hydroxapatite in composite is present in rod-like particles, which 
create various structures - agglomerates. All the results show emerging of HA agglomerates 
which in the case of 40HA and 50HA hydroxyapatite crystals grow into surfaces and cause 
the roughness of the samples. The pure PVA membrane was clear (not present). The 10HA 
contains small and rare occuring plates-like agglomaterates, which are consist of HA needles. 
A few solitary HA needles can be found too. The 20HA contains differently shaped 
agglomerates from 10HA. Short agglomerated clusters of HA needles were found in 20HA 
samples as well as plenty of HA needles distributed itself in the PVA matrix. The 30HA 
contains plenty of very similar structures as the 10HA, but in multiple amount. The long 
shaped clusters were observed and alone HA needles as well. The 40HA specimen shows that 
the matrix is saturated with the HA filler. The HA is dispersed all over the testing area and 
obviously the HA grows into the surface of the membrane and causes its roughness. The 
50HA specimen was difficult to observe, because electron beam did interact with the sample 
during scanning, that‘s why the surface was gilded. The 50HA shows huge agglomerates, 
which grow through the surface and made the specimen very rough. The detailed view of HA 
spherical particles used to form the PVA/HA composites is displayed in Fig. 25. The particles 
were of micro and nano size. 
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Figure 20: SEM image of 10HA at 150x magnification 
 
Figure 21: SEM image of 20HA at 150x magnification 
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Figure 22: SEM image of 30HA at 150x magnification 
 
Figure 23: SEM image of 40HA at 150x magnification 
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Figure 24: SEM image of 50HA at 150x magnification 
 
 
Figure 25: Shows detailed view of HA particles at 5000 magnification  
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Figure 26: Cut along the membrane showing visible layer of the hydroxyapatite in the 30HA 
 
Figure 26 depicts the cut along the 30HA membrane. The filler is visibly separated into two 
zones due to the action of of partial sedimentation of HA particles during drying process.  
The morphology of HA particles in the composite membranes was changed, not only, due to 
the filler concentration, but also due to the temperature (30 °C) and time of membranes 
preparation (7 days). These conditions have greatly influenced the HA crystal growth. 
5.4 Tensile properties 
The mechanical behavior of the composite with various weight ratios of HA particles in terms 
stress-strain dependence is displayed in Fig. 27. The results show, that HA addition influences 
the mechanical properties of the composites. The resulted values were averaged (see Table 6) 
from 5 accomplished measurements.  
Pure PVA shows a curve with yield point, which indicates transition between elastic and 
plastic deformation, in the case of composites, this point is not observed clearly.  
Curves of composite have three zones - the first is characterised by an increase in the load 
accompanied by extension of the film, followed by a zone in which the extension occurs with 
slight increases in the load and the point of rupture of the membranes. The samples formed 
necking and white zone before rupture. The failure appears to be ductile for all the tested 
samples. 
The significant values of the measurement are noted in Table 6. Maximum tensile stress was 
the highest in the case of 10HA, i.e. 55  MPa. Compared to the pure PVA, the 10HA and 
20HA had higher maximum stress. The increase in the case of 10HA was 17% and 20HA was 
8%. The sample 30HA had maximum tensile stress lower than that of the PVA, it was 42 MPa 
and the decrease was 11%, samples 40HA and 50HA had distinctly lower values of maximum 
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tensile stress than pure polymer, namely 32 MPa and 27 MPa for 50HA, which made the 
decrease up to 32% and 42% comparing to the neat polymer. 
The next value is the Young’s modulus, as the content of HA increased further, the Young’s 
modulus of the composites presented decreasing trend. The pure PVA has the value at 
662 MPa, very close to this value was 10HA composite with 644 MPa. Similar value of 
Young’s modulus was observed for 20HA and 40HA composites at 383 MPa and 382 MPa 
and the lowest was 50HA composite with 247 MPa.  
Tensile stress at break have increased in comparison with the pure PVA in the case of 10HA 
and 20HA composites, this followed the trend of the maximum stress values. The increase in 
the case of 10HA was 29% and 14% for 20 HA. When the HA content in the composite 
reached 30%, the stress at break decreased. For 30HA, the decrease was 5% and then steeply 
39% decrease for 40HA and 51% for 50HA. 
Elongation at break in % compared with the pure PVA decreased for all the composites, the 
decrease was non-linear. The highest value of percentage of elongation was observed for neat 
polymer, this was 226%, the composite elongation was lower, the lowest for 20HA, then 
10HA and then in ordered from lowest to highest 50HA → 30HA → 40HA. 
Zheng et al.[121] presented results where the tensile strength and modulus of PVA/HA 
composite hydrogel increased with HA content. The viscosity of composite hydrogel was 
enhanced and its stress relaxation performance was more similar to natural cartilage. Li et 
al.[122] showed that the tensile strength of PVA/HA composite hydrogel first increased and 
then decreased with the increase in HA content. It was found, that the tensile strength 
achieved the maximum value when HA concentration was 7.5%. As HA content further 
increased the tensile strength decreased. 
In this survey the values of tensile strength are improved for 10HA and 20HA in comparison 
with the pure PVA (0HA). The increasing amount of HA deteriorates the tensile strength, this 
may be caused by generating of HA agglomerates. 
The SEM Fig. 28 shows rough surface which belongs to direction of the loading during 
testing for the 30HA specimen. Figures 29 and 30 show the edge (fracture surface) after tear 
apart. 
 
Table 6: Tensile properties of prepared membranes 
Sample Maximum 
tensile stress 
(MPa) 
Young’s 
modulus 
(MPa) 
Tensile stress 
at break (MPa) 
Elongation at 
break (%) 
0HA 47 662 41 226 
10HA 55 644 53 156 
20HA 51 383 47 140 
30HA 42 362 39 181 
40HA 32 382 25 185 
50HA 27 247 20 177 
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Figure 27: Stress/strain characteristics of the PVA/HA composite  
 
 
 
Graph 2: The effect of HA content in PVA/HA composite on tensile modulus 
 
The mechanical properties of the polymer are expected to be improved effectively by adding 
inorganic nanoparticles into polymer matrix due to their high mechanical strength and surface 
energy [98]. Ideally the interfacial bonding can effectively transfer the load from the matrix to 
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the reinforcement and weak interfacial bonding can deflect an advancing crack thus providing 
enhanced fracture toughness and avoiding catastrophic failure [44]. 
Contrarily, the nano-HA particles can easily agglomerate because of its high surface active 
energy, while the content of nano-HA exceeding a certain percent. The local agglomeration of 
nano-HA particles can not act as a reinforcement phase but can become the original defective 
region, which deteriorates the tensile strength of the composites [123]. 
 
 
 
 
Figure 28: SEM image of the tensile impact fracture surfaces of the sample 30HA at 100 
magnification 
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Figure 29: SEM image of sample 30HA after tensile strength testing – the impact edge at 100 
magnification 
 
 
Figure 30: Detail of the impact edge with visible HA and PVA phase after tensile testing of 
30HA 
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5.5 Thermogravimetric analysis 
5.5.1 PVA thermal decomposition 
The thermal degradation of PVA under 300 °C the major pyrolysis product has been reported 
to be water, produced by the elimination of hydroxyl side-groups [124, 125].  
Peng [126] investigated PVA/SiO2 nanocomposite, where he described two steps of PVA 
thermal decomposition (Fig. 31 – 33). The first degradation step are elimination reactions. 
The elimination reactions of linear and aliphatic polymers including PVA in the first stage of 
thermal degradation mainly form polyene structures via dehydration [127, 128]. 
The degradation temperature of the first degradation step is not high enough to break all the 
backbone chains of these polyenes into low-molecular-weight polyenes. Most of these 
polyene structures acts as intermediate products and is further degraded into other products 
with lower molecular weights at the next degradation step, which is chain-scission reactions. 
The degradation products of the second degradation step are acetaldehyde, acetic acid, 
polyenes, benzenoid derivatives and a small amount of furan  
As the second step of thermal degradation occurs at higher temperatures compared to the first 
step, it becomes more complex. At this step, the degradation is dominated by the chain-
scission reactions, side-reactions and cyclization reactions. A continual degradation of residua 
acetate groups is also found. Furan is formed by intramolecular cyclizations [126]. 
 
Table 7: The physical appearance during thermal decomposition of PVA [129]. 
Material Appearance 
PVA White solid 
250°C Char (30 min) Yellow-orange foam 
300°C Char (30 min) Tan rigid foam 
350°C Char (30 min) Dark brown foam 
400°C Char (30 min) Black powder 
53 
 
 
Figure 31: Elimination reaction – H2O realising 
 
 
Figure 32: Chain scission reactions in the first degradation step 
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Figure 33: Chain scission reactions 
5.5.2 HA thermal decomposition 
The decomposition of HA proceeds in two stages: reversible expulsion of water producing 
oxyapatite (OA), and irreversible decomposition to HA yielding calciumphosphates [130]. 
HA is a hydrated calcium phosphate material. It begins to dehydroxylate at about 800 °C to 
form oxyhydroxyapatite, or Ca10(PO4)6(OH)2-2xOx• x, where • =vacancy. Furthermore, HA 
also decomposes to form other calcium phosphates at elevated temperatures. Two 
mechanisms have been proposed for the decomposition as follows: 
Further heating results in the transformation of -tricalcium phosphate (-Ca3(PO4)2), forming 
-tricalcium phosphate. This usually requires exposure to temperatures in excess of 1350 °C 
for this phase transformation to take place. Two mechanisms have been proposed for the 
decomposition as follows: 
 
Ca10(PO4)6(OH)2↔2β-Ca3(PO4)2 + Ca4P2O9 + ↑H2O           (10) 
 
Ca10(PO4)6(OH)2↔3β-Ca3(PO4)2 + CaO + ↑H2O            (11) 
 
Of these, the former is the more accepted mechanism. 
 
Regardless of which mechanism takes place, both result in the formation of soluble or 
resorbable calcium phosphates, which dissolve when exposed to physiological environments 
[131]. 
5.5.3 PVA thermogravimetry analysis 
The course of thermogravimetric curve of pure PVA(0HA) shows 3 main degradation steps, 
which are clearly expressed with DTG – derivated TG curve (Fig. 34). 
The initial weight loss for the pure PVA occurred at a temperature range of 37 to 200 °C with 
a peak at  156 °C in the DTG curve (Tmax,1 = 156 °C), due to the evaporation of physically 
weak and chemically strong bound H2O from the polymer matrix. The weight loss was about 
7,5 wt%. The next major weight losses have been observed in the range  of 250 to 415 °C 
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(Tmax,2 = 368 °C). This was due to the degradation of side chain (O–H) of PVA and the 
weight loss at this stage was about 68 wt%. The last peak of the third stage temperature range 
between 450 and 500 °C (Tmax,3 = 461 °C). This may correspond to the cleavage of C–C 
backbone of PVA polymer or commonly called carbonation with a weight loss of 16 wt%. 
 
Figure 34: TGA curve of pure PVA (0HA) 
 
5.5.4 Hydroxyapatite thermogravimetry analysis 
The decomposition of the pure HA powder was monitored up to 900 °C (Fig. 35). There was 
revealed one significant peak at DTG curve around 272 °C, which belongs to massive loss of 
physically bond water from hydroxyapatite structure. This mass loss was near 25 wt%  in 
range 200 – 300 °C. 
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Figure 35: TGA curve of pure hydroxyapatite powder (100HA) 
 
5.5.5 PVA/HA composite thermogravimetry analysis ¨ 
The main loss of weight in composite shows peaks in DTG curves and declination of the TGA 
curve. The thermograms of all measured PVA/HA composites show common features. The 
main weight loss carry out in three ranges. The first one takes place by 250 °C, the second 
range is approximately between 250 and 450 °C and the last one 450 °C and higher.  
Table 8: Weight loss of PVA/HA composites with variable HA content in PVA matrix sorted 
into three temperature ranges 
Sample 1st Range 2nd Range 3rd Range 
T [°C] Weight 
loss [%] 
T [°C] Weight 
loss [%] 
T [°C] Weight 
loss [%] 
10HA 37 - 230 14.9 250 – 450 49.6 450– 540 18.9 
20HA 37 - 240 17.0 260 – 430 43.1 430– 530 15.8 
30HA 37 – 250 19.9 270 – 420 41.8 430– 500 10.7 
40HA 37 - 210 22.9 250 – 400 35.0 500- 630 15.0 
50HA 37 - 200 31.9 250 - 400 25.5 450- 600 21.0 
 
First temperature range reveals, that with increasing hydroxyapatite in PVA matrix increases 
weight loss. This phenomenon  migh be explained as weight realeasing in form of water from 
hydroxyapatite and breaking of weak bonds between matrix and the filler. 
 
The second range, approx. between 250 and 450 °C shows opposite tendency comparing to 
previous range, so with increasing amount of HA in PVA matrix, the weight loss decreases. 
57 
 
It was also found out, that the interval of decomposition is shortened, so the broadest is in 
10HA. The temperature range is in line from the lowest presence of HA to the highest wide  
200, 160, 160, 150 and 150 °C. 
The weight loss in this range is influenced by both – the filler and the matrix decomposition, 
as the hydroxyapatite has its main weight loss in this survey between 200 – 300 °C, and it is 
25%wt. and the PVA which show in range 250 – 450 °C massive weight loss about 68%. This 
loss is associated with the degradation of PVA polymer membrane.  
The third decomposition region is in range approx. 450 °C and higher, which is due to due to 
the cleavage backbone of PVA polymer membrane (or so-called carbonation).  
The 20HA shows peculiar run of the curve at around 240 °C, this was recorded the bouncing 
measuring pan during testing which was caused by foaming of the PVA in the sample at this 
temperature. 
The PVA/HA composite shows improved resistence in comparison with the pure PVA. 
Degradation temperatures of the composite are noticeably higher which is due to interfacial 
bonding between HA particles and the PVA polymer matrix. 
The total weight loss was determined at all of the measured samples at 900 °C and as 
expected, the highest residue was noticed at pure HA, the lowest at pure PVA and according 
to amount of HA in PVA matrix. The results of the measurement are noticed in Tab. 9. 
All TGA curves od PVA/HA composites are displayed in Appendix (Figures 49 - 55). 
 
 
Figure 36: TGA curve of composite 10HA  
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Table 9: Comparison of total weight loss at 900°C  
Sample Total weight loss at 900°C in % 
0HA 98.99 
10 HA 92.61 
20 HA 90.82 
30 HA 85.40 
40 HA 80.39 
50 HA 79.50 
100 HA 33.04 
 
 
The residuum of the TGA measured samples was a white powder, which was further analysed 
by XRD measurement, which showed supposed  results - equations (section 5.5.2). After 
TGA analysis, there was found rest of not fully decomposed hydroxyapatite and calcium 
phosphate Ca3(PO4)2. Polyvinyl alcohol was not more found in sample, but whitlockite as 
product of partial decomposition of HA (Fig. 37). 
 
Figure 37: XRD spectrum of 20HA composite after TGA analysis 
5.6 Bioactivity testing 
Samples removed from the microincubator were rinsed with distilled water and dried at 
laboratory temperature.  All the samples were weighed before and after the SBF immersion to 
compare weight loss respectively estimate the biodegradation of the composite. The weight 
loss was calculated according to percentage of initial weight. These results are depicted in 
Tab. 10. There are not included samples soaking for two hours as the weigh loss was 
negligible. It is obvious, that HA content strongly influences the degradation rate of the 
composite. The weigh loss was as expexted highest in the case of pure PVA and stepped up 
with the increasing time soaked in SBF. Conversely the lowest weight loss was registered in 
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the case of 50HA, this is due to high content of HA in PVA matrix and because of new HA 
formation. Nie [132] tested foamed BCP/PVA bodies and the results described the same 
degradation effect, but the degradation rate was higher because of higher contact area. 
Graphical representation of weight change see in Fig. 38. The limitation of PVA are obvious, 
including fast hydrolysis [132] and its bioinert nature [133] that hinder protein and cell 
adhesion [134]. This requires the incorporation of component, which reduces the rate and time 
of biodegradation, this demand fulfills hydroxyapatite. 
 
Table 10:Weigh loss of PVA/HA biocomposites in testing time  
 Weight loss 
after 7 days [%] 
Weight loss after 
28 days [%] 
0HA 14.2 21.0 
10HA 11.1 20.1 
20HA 10.1 17.3 
30HA 7.0 12.4 
40HA 4.9 7.2 
50HA 3.0 5.0 
 
 
 
Figure 38: Increasing weight loss of composites and the pure PVA in time 
 
The Fig. 39 displays macroscopic comparison of tested membranes after 7 days of SBF 
bioactivity testing. The membranes were flat before testing, the picture shows change in 
shape, as the samples were faced with flowing 37°C warm solution.  
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Figure 39: Shows macroscopic comparison of membranes with various HA content in PVA 
matrix, from left to right 0HA, 10HA, 20HA, 30HA, 40HA and 50HA after 7 days of SBF 
soaking. 
 
 
The SEM pictures Fig. 40 - 43 display HA formation on the surface of 50HA composite 
during testing periods.  
HA crystals were observed on all composite membranes just after 2 hours of soaking in SBF. 
Most of the membranes surface was entirely covered with crystals after 7 days of soaking in 
SBF. Fig. 44 – 46 depict corresponding change of surface roughness during testing periods. 
The number of nucleation locations of apatite crystals was adequate to the experimental time 
and the apatite layer formed more rapidly on composite with higher content of HA.  
The in vitro testing proved high bioactive properties of the PVA/HA composites. The 
possibility to manage the rate of bioactivity makes PVA/HA composite suitable to fulfill 
diverse requirements and can be useful as tailor-made materials for medical application. 
 
 
 
Figure 40: Surface morphology of 50HA before soaking in SBF 
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Figure 41: Surface morphology of 50HA after soaking  in SBF for 2 hours 
 
 
Figure 42: Surface morphology of 50HA after soaking in SBF for 28 days 
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Figure 43: Detail of new formed hydroxyapatite on the surface 
 
5.6.1 Surface Roughness 
 
Figure 44: Study of surface change during testing periods – 50HA before soaking in SBF 
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Figure 45: Study of surface change during testing periods – 50HA after 2 hours of soaking in 
SBF 
 
 
Figure 46: Study of surface change during testing periods – 50HA after 28 days of soaking in 
SBF  
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The newly formed layer was analysed by XRD analysis, which proved HA on the surface - 
Fig. 47 and 48. The diffractograms should be not considered as quantitative analysis, because 
of the high amount amorphous phase in the membranes, this misrepresents the results. 
 
 
Figure 47: Diffractogram of 50HA composite surface after 7 days of soaking in SBF 
 
 
Figure 48: Diffractogram of 50HA composite surface after 28 days of soaking in SBF 
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6 CONCLUSION 
The aim of the work was to synthesize biocomposite poly(vinyl alcohol) membranes 
reinforced  with particles of hydroxyapatite and to characterise the properties of the 
composites. The main part of the work was focused on study of the in vitro bioactivity of 
synthesized membrane biocomposites.  
 
As the first step, hydroxyapatite was prepared by action of diammonium hydrogen phosphate 
(NH4)2HPO4 on calcium nitrate tetrahydrate Ca(NO3)2.4H2O in the presence of ammonium 
hydroxide NH4OH in water enviroment to form yogurt-like supension. After washing the 
ammonium ions out, the solution was further used to prepare PVA/HA composite membranes 
with various weight HA content. The prepared composites were characterised by various 
methods and the bioactivity of the material was also tested. 
 
ATR-FTIR spectroscopy was used to identify the different functional groups in composite 
membranes and composite components (HA filler, PVA matrix) itselves. The bonding 
between HA and PVA appeared in spectra after composite formation. 
 
The SEM was used to determine surface morfology of synthesized composite membranes and 
the influence of HA amount on morfology. The dried HA was observed and it was round 
particles before processed into composite. The HA changed its structure after composite 
formation, there were detected needles shaped structures, which created clusters of various 
shapes. The agglomerates amounts increased with increasing wt% amount of HA. The change 
in morfology was caused not only by amount of HA in PVA matrix, but also because of the 
procedure, which was used to synthesize the membranes. They were dried for 7 days at 30°C. 
These condition caused HA crystal growth and the agglomeration trend as well. 
 
The tensile testing was used to compare pure PVA and composites mechanical properties. 
There was a noticeable influence of HA filler. The values of tensile strength are improved for 
10HA and 20HA in comparison with the pure PVA. The increasing amount of HA 
deteriorated the tensile strength, this was probably caused by HA agglomerates. 
 
The bioactivity testing results indicated that the synthesized HA/PVA composite membranes 
showed the high bioactivity in vitro in the SBF solution. At all the tested membranes new 
apatite layer was formed, this was detected with SEM measurements. The tested samples 
showed weight loss after SBF soaking which decreases with increasing content of HA in the 
PVA matrix, this was caused by biodegradation ability of PVA. The bioactivity of membrane 
containing 50 % of HA had the highest ability to form the apatite and the layer increased with 
increasing soaking time. This ability makes the composite a suitable candidate for 
applications as artificial cartilage. 
 
The main contributions of this work is that PVA/HA biocomposites were characterised with 
wide scope of methods. In the case of FTIR, the bonding between components was detected, 
the thermal stability of the composites was improved in comparison to the pure PVA and the 
mechanical properties were strongly influenced with bioceramic filler. The distribution and 
the arragement of the HA crystals were observed with SEM. Finally the in vitro method was 
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used for the study of the membranes, this test allows prediction of the approximate behaviour 
of such materials in vivo.The bioactivity was proved due to formation of new HA layer on the 
membranes surface.  
 
Due to rapid advances made in this research area, it was not possible to include all points of 
view in the work. There are still tasks which should be focused on in future work. 
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7 FUTURE WORK  
Because of the synthesized hydroxyapatite was both micro and nano sized, the next synthesis 
will be focused on production of nano-sized particles only. The different technique methods 
to prepare the composites are required to avoid HA crystals growth and homogeneous 
dispersion of nanoparticle fillers in the matrix of biopolymers. Investigated samples could be 
membranes or porous bodies composed of hydoxyapatite with polymer as fillers. The in vitro 
bioactivity testing gave us an information about the host tissue response to the biocomposite, 
the future studies could be more focused on bioactivity and on in vivo behaviour. 
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12 APPENDIX 
12.1 TGA results 
 
Figure 49: TGA curve of pure PVA (0HA) 
 
Figure 50: TGA curve of pure hydroxyapatite powder (100HA) 
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Figure 51: TGA curve of composite 10HA  
 
 
Figure 52: TGA curve of composite 20HA 
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Figure 53: TGA curve of composite 30HA 
 
 
Figure 54: TGA curve of composite 40HA 
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Figure 55: TGA curve of composite 50HA 
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